(Total Views: 81)
Posted On: 02/12/2019 11:57:41 AM
Post# of 44029
$LILY:CSE $MPHMF $MWX.V $MWXRF
CannaStripts Revolutionary in CBD Market Expected to exceed $22 Billion by 2022
Callitas Health, Inc. (OTCQB: MPHMF | CSE: LILY | FSE: T3F3) an integrated clinical-stage pharmaceutical development, OTC consumer goods company focusing on targeting cannabinoid delivery products and other proprietary drugs in the area of weight management, female sexual health/wellness and female reproduction. - "CannaStrips" News Alert Today! Volume Increasing - Watch Video Now! -- Progressively Diversified Medical Cannabis Company -- One to Watch in 2019 Look Here Now! – 52 Week High $0.40 CAD and $0.284 USD - Time To Buy! See More Now!
http://www.thestreetnow.com/spotlight/ur/
CannaStripts Revolutionary in CBD Market Expected to exceed $22 Billion by 2022
Callitas Health, Inc. (OTCQB: MPHMF | CSE: LILY | FSE: T3F3) an integrated clinical-stage pharmaceutical development, OTC consumer goods company focusing on targeting cannabinoid delivery products and other proprietary drugs in the area of weight management, female sexual health/wellness and female reproduction. - "CannaStrips" News Alert Today! Volume Increasing - Watch Video Now! -- Progressively Diversified Medical Cannabis Company -- One to Watch in 2019 Look Here Now! – 52 Week High $0.40 CAD and $0.284 USD - Time To Buy! See More Now!
http://www.thestreetnow.com/spotlight/ur/
(0)
(0)
